Viking Therapeutics Inc. (VKTX)
25.71
-3.16 (-10.95%)
At close: Mar 03, 2025, 3:59 PM
25.70
-0.04%
After-hours: Mar 03, 2025, 07:58 PM EST
Viking Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -109.96M | -85.89M | -68.87M | -54.99M | -39.49M | -25.78M | -22.06M | -20.58M | -14.73M | -23.4M | -21.88M | -146.25K | -444.11 |
| Depreciation & Amortization | -17.17M | 292K | 291K | 296K | 277K | 260K | 477K | 1.38M | 1.94M | 1.03M | n/a | n/a | n/a |
| Stock-Based Compensation | 29.71M | 16.75M | 8.67M | 6.1M | 5.82M | 3.74M | 2.61M | 1.45M | 1.79M | 2.6M | 6.26K | 3.55 | 22.45 |
| Other Working Capital | 5.86M | 4.25M | 3.1M | -383K | 6.16M | -5.25M | 1.33M | 1.51M | 172.69K | 401.08K | 21.75M | 5.38K | n/a |
| Other Non-Cash Items | 272K | -8.07M | 1.32M | 29K | 138K | 334K | -208K | 2.5M | 862.62K | 11.32M | -1.65M | 42.57K | 244.11 |
| Deferred Income Tax | n/a | n/a | n/a | 3.91M | 3.77M | 473K | -392K | -1.28M | -1.79M | -893.5K | n/a | n/a | n/a |
| Change in Working Capital | 9.36M | 3.55M | 10.19M | -2.93M | 7.72M | -3.78M | 823K | 1.77M | 849.88K | 620.32K | 21.94M | 25.44K | n/a |
| Operating Cash Flow | -87.79M | -73.38M | -48.4M | -47.59M | -21.78M | -24.75M | -18.75M | -14.76M | -11.07M | -8.73M | -1.59M | -78.23K | -200 |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -1.11B | -478.3M | -121.43M | -168.01M | -280.64M | -362.41M | -348.2M | -22.53M | -16.92M | -16.03M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 561.2M | 299.22M | 176.18M | 205.97M | 322.2M | 369.87M | 82.47M | 20.8M | 19.95M | 2.56M | n/a | n/a | n/a |
| Other Investing Acitivies | -1.2M | n/a | 54.75K | 37.96K | 41.57K | 7.46K | -265.73K | -1.73K | 3.03K | -13.47K | n/a | n/a | n/a |
| Investing Cash Flow | -553.37M | -179.09M | 54.75M | 37.96M | 41.57M | 7.46M | -265.73M | -1.73M | 3.03M | -13.47M | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -3.83M | -77K | -94.86K | n/a | 2.5M | 260.35K | n/a |
| Common Stock Repurchased | n/a | -7.12M | -6.79M | -707 | -296 | -151 | n/a | n/a | -229 | -38 | -2 | -2.5K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 15.37M | 271.38M | 10.96M | 6.88M | 950K | 887K | 7.5M | 125.45K | -1.1M | -3.18M | -332.34K | n/a | 200.00 |
| Financial Cash Flow | 612.46M | 271.38M | 4.16M | 6.88M | 950K | 887K | 300.27M | 22.4M | 10.35M | 22.21M | 2.17M | 257.85K | 200.00 |
| Net Cash Flow | -28.84M | 18.88M | 10.26M | -2.75M | 20.74M | -16.4M | 15.79M | 5.91M | 2.31M | 12.69K | 576.24K | 179.62K | n/a |
| Free Cash Flow | -87.79M | -73.38M | -48.4M | -47.59M | -21.78M | -24.75M | -18.75M | -14.76M | -11.07M | -8.73M | -1.59M | -78.23K | -200 |